Evidence map›Paper›PMID 30291407›Full record

ReviewDer Radiologe2018

[Biopsies of kidney lesions: when and how?]

A H Schuster, N Reimann

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Radiologe, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A H SchusterLehrabteilung der Universität Innsbruck, Abteilung Radiologie, University of Innsbruck and Medical University of Innsbruck, Landeskrankenhaus Bregenz, Akademisches Lehrkrankenhaus, Carl-Pedenz-Straße 2, 6900, Bregenz, Österreich. antonius.schuster@lkhb.at.
N ReimannLehrabteilung der Universität Innsbruck, Abteilung Radiologie, University of Innsbruck and Medical University of Innsbruck, Landeskrankenhaus Bregenz, Akademisches Lehrkrankenhaus, Carl-Pedenz-Straße 2, 6900, Bregenz, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demand for image-guided renal biopsy has increased due to the better detection of renal lesions; however, despite modern imaging techniques many small renal tumors cannot be classified as benign because they cannot be differentiated from renal cell carcinoma. Ultrasound and computed tomography (CT)-guided kidney biopsy is a safe and accurate method in the diagnostics of renal lesions and can be helpful in the selection of new ablative and pharmaceutical forms of treatment and avoid unnecessary operations. This article describes the clinical indications for an image-guided biopsy and discusses factors which should be considered when performing a biopsy.

Indexed as

Carcinoma, Renal CellImage-Guided BiopsyKidney NeoplasmsHumansKidneyTomography, X-Ray ComputedComputed tomographyImage-guided biopsyKidneyMagnetic resonance imagingUltrasound

Identifiers

PMID30291407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.